Pre-Market Surge For CytoMed (GDTC) Amid Strategic Partnership News
CytoMed Therapeutics Limited (NASDAQ: GDTC) shares are witnessing a remarkable 19.42% surge in pre-market trading, climbing to $4.12. This significant uptick in GDTC stock followed the announcement of a pivotal collaboration agreement, positioning the company for promising advancements in cancer immunotherapy. Groundbreaking Partnership with SunAct Cancer Institute In order to investigate the therapeutic potential of […]
Pre-Market Surge For CytoMed (GDTC) Amid Strategic Partnership News Read More »